On the recordMarch 12, 2019
And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to make sure that we are dealing with this problem up front because the problem that we have seen over the last 5 or 6 years where coverage has shrunk some as the cost of drugs has gotten higher and higher that is a dangerous warning sign for what is to come if there isn't some kind of approach that looks to the future of these drugs, as Congressman Burgess said million dollar drugs for various therapies start coming to market. We need a more rational way to do this.
Source
congress.gov
